Stay updated on DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, replacing v3.4.1; no core study content or user-facing details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T16:24:19.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.4.1 appears on the page, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:35:33.000Z thumbnail image
  4. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1. No visible content or layout changes to the study page were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T13:37:37.000Z thumbnail image
  5. Check
    27 days ago
    Change Detected
    Summary
    UI and metadata updates include enabling Show glossary, capitalization adjustments to QC-related labels (Last Update Submitted that Met QC Criteria and No FEAR Act data), and a site revision upgrade to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-29T06:25:25.000Z thumbnail image
  6. Check
    34 days ago
    Change Detected
    Summary
    Last Update Posted timestamp is now displayed, and the Last Update Posted (Estimated) label has been removed.
    Difference
    0.0%
    Check dated 2026-01-22T05:16:43.000Z thumbnail image
  7. Check
    41 days ago
    Change Detected
    Summary
    Updated the page revision to v3.3.4, replacing the previous v3.3.3. This is a minor, behind-the-scenes update that does not affect study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T02:55:02.000Z thumbnail image

Stay in the know with updates to DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.